MNPR Competitors & Alternatives

Compare Monopar Therapeutics Inc with similar stocks in the same industry

Biotechnology

MNPR

Main Stock
$63.58
Tradestie Score
57
Market Cap
$522.78M
Analyst Upside
+77.4%

Top Competitors

229 stocks in Biotechnology
Company Price Market Cap P/E Score Action
SLDB Solid Biosciences Inc. Common Stock
$7.27
$457.09M - 54 Compare
MRVI Maravai LifeSciences Holdings, Inc. Class A Common Stock
$4.85
$454.29M - 59 Compare
RAPT RAPT Therapeutics, Inc. Common Stock
$58.02
$450.49M - 53 Compare
MLTX MoonLake Immunotherapeutics Class A Ordinary Shares
$17.06
$448.32M - 56 Compare
ATXS Astria Therapeutics, Inc. Common Stock
$12.58
$425.52M - 58 Compare
ALMS Alumis Inc. Common Stock
$23.66
$422.50M - 54 Compare
DRUG Bright Minds Biosciences Inc. Common Stock
$85.50
$410.79M - 57 Compare
FDMT 4D Molecular Therapeutics, Inc. Common Stock
$10.14
$407.71M - 60 Compare
DSGN Design Therapeutics, Inc. Common Stock
$14.22
$386.68M - 60 Compare
AURA Aura Biosciences, Inc. Common Stock
$8.40
$382.04M - 57 Compare

Data updated: May 10, 2026 | Industry: Biotechnology (SIC 2834)

229 stocks in this industry